Note (a): Systemic therapy is treatment administered through any route other than the skin; topical therapy is treatment administered through the skin.
Note (b): Two or more skin conditions may be combined under § 4.25 only if separate skin areas are involved. If the same area is involved, only the highest evaluation applies.
| Description | Rating |
|---|---|
| 7827 Erythema multiforme; Toxic epidermal necrolysis: | |
| Recurrent mucosal, palmar, or plantar involvement impairing mastication, use of hands, or ambulation occurring four or more times over the past 12-month period despite ongoing immunosuppressive therapy | 60 |
| All of the following | 30 |
| Recurrent mucosal, palmar, or plantar involvement not impairing mastication, use of hands, or ambulation, occurring four or more times over the past 12-month period; and requiring intermittent systemic therapy | |
| At least one of the following | 10 |
| One to three episodes of mucosal, palmar, or plantar involvement not impairing mastication, use of hands, or ambulation, occurring over the past 12-month period AND requiring intermittent systemic therapy; or | |
| Without recurrent episodes, but requiring continuous systemic medication for control | |
| Or rate as disfigurement of the head, face, or neck (DC 7800) or scars (DCs 7801, 7802, 7804, or 7805), depending upon the predominant disability | |
| Note: For the purposes of this DC only, systemic therapy may consist of one or more of the following treatment agents: immunosuppressives, antihistamines, or sympathomimetics |